NASDAQ:OGI (OrganiGram Holdings)
About
Last updated Jan 20, 2021, 03:22:10pm ESTRelated Articles
3 Pot Stocks to Avoid Like the Plague in 2021
Aditya Raghunath | January 14, 2021
Here's why investors should be wary of investing in loss-making pot stocks such as Aurora Cannabis. More »
Are Cannabis Stock Investors Too Harsh on Organigram?
Brian Paradza, CFA | January 13, 2021
Was a 12% decline in cannabis firm Organigram's stock price well deserved on Tuesday? More »
2 Pot Stocks That Can Double in 2021
Aditya Raghunath | January 5, 2021
Here's why cannabis investors can expect shares of Cresco Labs and OrganiGram to double in 2021. More »
3 Pot Stocks Robinhood Investors Should Avoid in 2021
Aditya Raghunath | December 11, 2020
Here's why Robinhood investors should avoid investing in pot stocks such as Aurora Cannabis (TSX:ACB) and Hexo (TSX:HEXO). More »
These 3 TSX Stocks Report Their Earnings Next Week: Should You Buy?
Rajiv Nanjapla | November 26, 2020
Bank of Nova Scotia and Descartes Systems look attractive ahead of their earnings, but avoid OrganiGram. More »
Warren Buffett Investing: Time to Buy These Struggling Stocks?
Ambrose O'Callaghan | September 12, 2020
Warren Buffett is a proponent of value investing, but struggling stocks like Charlotte’s Web Holdings Inc. (TSX:CWEB) don’t necessarily fit this framework. More »
Is OrganiGram (TSX:OGI) Stock a Buy Before Earnings?
Aditya Raghunath | July 19, 2020
Down 80% from record highs, is it time to buy OrganiGram (TSX:OGI) stock? More »
If You Had Invested $500 in OrganiGram Stock 5 Years Back, It Would Be Worth This Much Today!
Aditya Raghunath | June 27, 2020
OrganiGram has outperformed broader markets in the last five years. Can it continue to do so in the upcoming decade? More »
Ranking 3 Top Marijuana Stocks for 2020
Aditya Raghunath | June 27, 2020
Here's why cannabis investors should buy profitable stocks such as Aphria (TSX:APHA) and OrganiGram (TSX:OGI) right now. More »
Is OrganiGram (TSX:OGI) Stock a Buy Right Now?
Aditya Raghunath | June 21, 2020
Here's why OgraniGram (TSX:OGI)(NASDAQ:OGI) stock might continue to underperform markets in 2020 More »